Sodium oxybate for narcolepsy. - sprookjes - yvandenbroek - TriplyDB

Sodium oxybate for narcolepsy.

Sodium oxybate for narcolepsy.

http://www.wikidata.org/entity/Q36558659

about

A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex.

P2860

Q38346952-5A69E63F-29B2-4882-AB73-B867DDEC98EA

P2860

Sodium oxybate for narcolepsy.

http://www.wikidata.org/entity/Q36558659

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Sodium oxybate for narcolepsy.

@ast

Sodium oxybate for narcolepsy.

@en

type

label

Sodium oxybate for narcolepsy.

@ast

Sodium oxybate for narcolepsy.

@en

prefLabel

Sodium oxybate for narcolepsy.

@ast

Sodium oxybate for narcolepsy.

@en

P1433

Q36558659-B7273312-B551-48C0-A0EF-8BC87A15B4DB

P1476

Q36558659-F63F148C-AB0F-4048-8F0C-E06A0D39EB91

P2093

Q36558659-D0ADC88E-622B-4C66-AAA1-0EC6F8633902

P2860

Q36558659-1025D7EC-B0AE-4B18-B059-E23B048DCEAD

Q36558659-1BCD58CC-0146-45AD-BF63-4636CBA4A313

Q36558659-2100F4AB-934B-42A8-AABD-6FFA00B92E06

Q36558659-27E2698C-15EE-4CA8-8CF9-AFB997C84D01

Q36558659-2B59ABBE-2FAD-45E9-B094-C98F95100937

Q36558659-2C6187A9-3381-4D67-83A3-0B20216267B4

Q36558659-3A0CFC7D-2E73-4DEC-8A7C-C20F4020A6BA

Q36558659-483236D4-9B02-4A2A-8CBF-A5B3AFD8274B

Q36558659-497E9CDF-5907-4738-9C7F-CB1519C29951

Q36558659-51649271-7B32-4CEB-8478-A3454FC9236A

P304

Q36558659-1B7C475E-FEB7-4196-9081-E03FC41369E4

P31

Q36558659-B5819A1C-9C8A-49B7-94A8-7712993D79AE

P356

Q36558659-BEE69524-78BA-4D91-B59E-50F8F26CCD58

P433

Q36558659-C3E562DB-5F16-4C8C-B6DA-5A6B0012BC85

P478

Q36558659-76D80BA2-08EB-40F6-B42C-95280F3C45C4

P577

Q36558659-25AC228E-6D13-40C1-AF98-C338EC630D17

P698

Q36558659-5730BDA7-0A44-49AD-8C52-AAAFF6DF232F

P921

Q36558659-CC3ED9E6-7B7D-4D66-B93B-8AD8581E5C06

P356

14737175.6.8.1139

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Sodium oxybate for narcolepsy.

@en

P2093

Martin B Scharf

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced number of hypocretin neurons in human narcolepsy.

Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Clinical aspects and pathophysiology of narcolepsy.

Autoimmune hypothesis in narcolepsy.

Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men.

Pharmacological aspects of human and canine narcolepsy.

From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid.

The Xyrem risk management program.

Pharmacotherapy for cataplexy.

P304

1139-1146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.6.8.1139

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16893342

http://www.w3.org/2001/XMLSchema#string

P921